Infectious Diseases News and Research

RSS

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

The 18th Conference on Retroviruses and Opportunistic Infections is being held at the Hynes Convention Center in Boston from February 27 through March 2. Day three of this major HIV/AIDS research conference included the following selected presentations from scientists supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Mar 2011

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

Today was the last day of the 18th Conference on Retroviruses and Opportunistic Infections, a key HIV/AIDS research meeting being held at the Hynes Convention Center in Boston from February 27 through March 2. Highlighted below are selected presentations from March 2nd on research supported by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, both components of the National Institutes of Health.

5 Mar 2011

Recent releases in Global Health

The Importance Of Investing In Adolescent Girls: A Lancet editorial examines the challenges adolescent girls living in developing countries face and the work of the U.N. Adolescent Girls Task Force to help young women overcome these barriers.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

Study: Vaccinated children and adolescents are less prone to infectious diseases

May vaccinations put too much strain on or weaken children's immune systems and are therefore harmful? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches Ärzteblatt International.

4 Mar 2011

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning "the whole treatment world on its head," according to Dartmouth pediatrician Paul Palumbo.

4 Mar 2011

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.

3 Mar 2011

Adherence counseling during HIV treatment greatly improves patient outcomes

Intensive adherence counseling around the time of HIV treatment initiation significantly reduces poor adherence and virologic treatment failure in sub-Saharan Africa, according to a recent study in PLoS Medicine by Dr. Michael Chung, assistant professor of Global Health at University of Washington, who works at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya.

3 Mar 2011

Seven-year study finds Group B strep as main cause of newborn bacterial meningitis

The Group B Streptococcus is still the most common cause of bacterial meningitis in newborns, concludes a seven-year French study in the March issue of The Pediatric Infectious Disease Journal.

3 Mar 2011

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2010.

2 Mar 2011

Accelr8 to present new BACcel test study results against hVISA in Europe

Accelr8 Technology Corporation announced that one of its outside principal investigators received acceptance to present results of a new study in Europe.

2 Mar 2011

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

2 Mar 2011

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

New research reveals how maternal antibodies block immune response to measles virus

New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say.

1 Mar 2011

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children.

1 Mar 2011

Meda launches Medivir's cold sore treatment Xerese in the U.S.

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces that the Company's commercialization partner, Meda AB, has launched Medivir's unique cold sore treatment Xerese in the United States.

1 Mar 2011

Renishaw launches first RUO multiplex assay system

Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of surface enhanced Raman scattering and surface enhanced resonance Raman scattering, for research and molecular diagnostics applications, today announced the launch of its first research use only multiplex assay system which allows precious research samples to be 'screened' for 10 or more 'targets', from a single sample.

1 Mar 2011

HHS awards two contracts to accelerate flu vaccine availability

U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.

28 Feb 2011

Infectious Diseases News and Research

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

Recent releases in Global Health

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Study: Vaccinated children and adolescents are less prone to infectious diseases

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

Adherence counseling during HIV treatment greatly improves patient outcomes

Seven-year study finds Group B strep as main cause of newborn bacterial meningitis

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Accelr8 to present new BACcel test study results against hVISA in Europe

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

New research reveals how maternal antibodies block immune response to measles virus

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Meda launches Medivir's cold sore treatment Xerese in the U.S.

Renishaw launches first RUO multiplex assay system

HHS awards two contracts to accelerate flu vaccine availability

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News